Tag

The research was scheduled for presentation Thursday at the annual Alzheimer’s Association worldwide Conference, held from July 18 to 23 in Washington, D.C.

The drugs aim to block the formation of a protein called beta amyloid, which is believed to cause the toxic brain plaques that are considered a hallmark of Alzheimer’s.